Chhaitanya Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 23-10-2024
- Paid Up Capital ₹ 2.20 M
as on 23-10-2024
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.10 Cr
as on 23-10-2024
- Satisfied Charges ₹ 8.93 M
as on 23-10-2024
- Revenue -6.58%
(FY 2023)
- Profit 770.92%
(FY 2023)
- Ebitda 380.20%
(FY 2023)
- Net Worth 12.61%
(FY 2023)
- Total Assets -14.82%
(FY 2023)
About Chhaitanya Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.20 M.
The company currently has active open charges totaling ₹30.10 Cr. The company has closed loans amounting to ₹8.93 M, as per Ministry of Corporate Affairs (MCA) records.
Rahul Sanan and Dharam Sanan serve as directors at the Company.
- CIN/LLPIN
U85110DL2002PTC116430
- Company No.
116430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chhaitanya Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Sanan  | Director | 05-Aug-2002 | Current |
| Dharam Sanan | Director | 07-Mar-2009 | Current |
Financial Performance of Chhaitanya Diagnostics.
Chhaitanya Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.58% decrease. The company also saw a substantial improvement in profitability, with a 770.92% increase in profit. The company's net worth Soared by an impressive increase of 12.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chhaitanya Diagnostics?
In 2023, Chhaitanya Diagnostics had a promoter holding of 90.91% and a public holding of 9.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- R V Diagnostics Private LimitedActive 21 years 6 months
Rahul Sanan and Dharam Sanan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Feb 2024 | ₹1.40 Cr | Open |
Others Creation Date: 18 Sep 2020 | ₹1.21 Cr | Open |
Others Creation Date: 31 Jul 2020 | ₹7.94 M | Open |
How Many Employees Work at Chhaitanya Diagnostics?
Chhaitanya Diagnostics has a workforce of 14 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chhaitanya Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chhaitanya Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
